About us
E25Bio revolves around an idea that technology that saves lives is in fact simple.
Our goal is to predict outbreaks around the world and help control them using unique and affordable testing solutions.
We've managed to develop an investigational SARS and SARS-CoV-2 rapid tests in 3 weeks
2020
jan
30
SARS-CoV-2 is a PHEIC
2020
feb
06
E25Bio high-throughput screen of existing mAbs
2020
feb
26
E25Bio develops SARS-CoV-2 rapid test
2020
mar
20
E25Bio partners with top academic Boston hospitals for scaled evaluation and production
After FDA EUA
Future
launch of rapid tests
Meet the team
Of scientists who invented and are developing an inexpensive yet accurate means of testing for COVID-19 and the people making it happen
Prashant Chouta
CEO
Irene Bosch, PhD
Co-founder & CTO
Bobby Brooke Herrera, PhD
Co-founder & CSO
Lee Gehrke, PhD
Co-founder/Scientific Advisory Board
Nol Salcedo, MSc
Scientist
Adam Gomez, MSc
Scientist
Carlos-Henri Ferré, MA
Director of Operations and Communications
Nik Lal
Design Engineer
Our investors
Without them, E25Bio wouldn’t be what it is today. So, the least we can do is to mention them.
